Clinical trial
An Open Label Study of Electroencephalographic Responses Pre, During and Post, a Low Dose, Weekly Intravenous Ketamine Infusion for 4 Weeks, in a Study Population With Major Depression Disorder
NCT05506462 is registered in ClinicalTrials.gov with Ehave Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open Label Study of Electroencephalographic Responses Pre, During and Post, a Low Dose, Weekly Intravenous Ketamine Infusion for 4 Weeks, in a Study Population With Major Depression Disorder
- Lead sponsor
- Ehave Inc.
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- January 31, 2023
- Completion date
- February 29, 2024
- Enrollment
- 35 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.